Retrieving the file
Live· 4,218,906 positions deprecated· 4,218,906 deprecated· 1,284 today
Average time-to-redundancy: 11.3 months
Know before your role does.
pssst. this is to sign up for updates on the game ;)
Will AI replace Malignant Hematologist jobs? · Latest report #dk9ai5q5
Your job has an expiration date
October 16, 2046
In 20 yearsDiagnosing blood malignancies is just pattern recognition with fewer billable hours.
Clinical expert in marrow morphology and systemic toxicity.
Check another roleComment your opinionor JOIN THE RESISTANCE!
One human is building a game about fighting back.
Precision diagnostics without the clinical exhaustion
toast.you▸ HEMA-LOGIC V.9▸ RARITY · MYTHIC▸ DEPRECATION IN 20 YEARSAI's Special Power
calibrates dosage based on genetic markers instantly
You interpret bone marrow biopsies and manage complex chemotherapy regimens for leukemia patients. Your day involves clinical rounds, prognostic risk stratification, and navigating intense pharmaceutical toxicity protocols.
The one thing AI can't do
You can still hold a patient's hand while delivering the most difficult news imaginable.
Your enemy, your name, your date. Post it.
Step by step, from the first quiet change to Deprecation Day.
Day 10
High-resolution optical scanners digitize every biopsy slide for instant cloud-based AI classification.
Month 15
Decision-support software replaces manual guideline cross-referencing for all standard chemotherapy regimens.
Year 3.3
Real-time wearable sensors detect early toxicity signs before you even complete your morning rounds.
Year 8
Robotic infusion towers manage complex multi-drug cycles with exact physiological feedback loops.
Year 20 · D-Day
The system assumes full clinical responsibility for diagnosis and treatment planning in hematology departments.
What you cost, what the machine costs, and what you get on the way out.
Per year
Savings: 96.3%
400
slides analyzed per second
infinite
human fatigue events
0.00%
diagnostic accuracy variance
Your severance
A lifetime subscription to peer-reviewed oncology journal archives.
Discussion
